HEADER HYDROLASE 10-APR-03 1P0I TITLE CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHOLINESTERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ACYLCHOLINE ACYLHYDROLASE, CHOLINE ESTERASE II, COMPND 5 BUTYRYLCHOLINE ESTERASE, PSEUDOCHOLINESTERASE; COMPND 6 EC: 3.1.1.8; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCHE OR CHE1; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: OVARY CELLS KEYWDS SERINE HYDROLASE, BUTYRATE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.NICOLET,O.LOCKRIDGE,P.MASSON,J.C.FONTECILLA-CAMPS,F.NACHON REVDAT 8 16-AUG-23 1P0I 1 REMARK REVDAT 7 27-OCT-21 1P0I 1 COMPND REMARK SEQADV HETNAM REVDAT 7 2 1 HETSYN REVDAT 6 29-JUL-20 1P0I 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE ATOM REVDAT 5 13-JUL-11 1P0I 1 VERSN REVDAT 4 24-FEB-09 1P0I 1 VERSN REVDAT 3 02-SEP-08 1P0I 1 REMARK REVDAT 2 18-JAN-05 1P0I 1 JRNL REVDAT 1 05-AUG-03 1P0I 0 JRNL AUTH Y.NICOLET,O.LOCKRIDGE,P.MASSON,J.C.FONTECILLA-CAMPS,F.NACHON JRNL TITL CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE AND OF ITS JRNL TITL 2 COMPLEXES WITH SUBSTRATE AND PRODUCTS. JRNL REF J.BIOL.CHEM. V. 278 41141 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12869558 JRNL DOI 10.1074/JBC.M210241200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH F.NACHON,Y.NICOLET,N.VIGUIE,P.MASSON,J.C.FONTECILLA-CAMPS, REMARK 1 AUTH 2 O.LOCKRIDGE REMARK 1 TITL ENGINEERING OF A MONOMERIC AND LOW-GLYCOSYLATED FORM OF REMARK 1 TITL 2 HUMAN BUTYRYLCHOLINESTERASE: EXPRESSION, PURIFICATION, REMARK 1 TITL 3 CHARACTERIZATION AND CRYSTALLIZATION REMARK 1 REF EUR.J.BIOCHEM. V. 269 630 2002 REMARK 1 REFN ISSN 0014-2956 REMARK 1 DOI 10.1046/J.0014-2956.2001.02692.X REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.8 REMARK 3 NUMBER OF REFLECTIONS : 49144 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2449 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7557 REMARK 3 BIN R VALUE (WORKING SET) : 0.2680 REMARK 3 BIN FREE R VALUE : 0.3250 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 402 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4166 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 166 REMARK 3 SOLVENT ATOMS : 483 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.67000 REMARK 3 B22 (A**2) : -3.67000 REMARK 3 B33 (A**2) : 7.34000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.23 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.29 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.080 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 4.210 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.790 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.770 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.940 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 109.5 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : WATER.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : LIGAND.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : WATER.TOP REMARK 3 TOPOLOGY FILE 5 : LIGAND.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1P0I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-APR-03. REMARK 100 THE DEPOSITION ID IS D_1000018865. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49144 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 55.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07400 REMARK 200 FOR THE DATA SET : 6.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.44800 REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2ACE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.82 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, 2-(N-MORPHOLINO) REMARK 280 -ETHANESULFONIC ACID, PH 6.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 9555 X+1/2,Y+1/2,Z+1/2 REMARK 290 10555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 11555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 12555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 13555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 14555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 15555 Y+1/2,X+1/2,-Z+1/2 REMARK 290 16555 -Y+1/2,-X+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 1.000000 0.000000 0.000000 77.33000 REMARK 290 SMTRY2 9 0.000000 1.000000 0.000000 77.33000 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 63.94500 REMARK 290 SMTRY1 10 -1.000000 0.000000 0.000000 77.33000 REMARK 290 SMTRY2 10 0.000000 -1.000000 0.000000 77.33000 REMARK 290 SMTRY3 10 0.000000 0.000000 1.000000 63.94500 REMARK 290 SMTRY1 11 0.000000 -1.000000 0.000000 77.33000 REMARK 290 SMTRY2 11 1.000000 0.000000 0.000000 77.33000 REMARK 290 SMTRY3 11 0.000000 0.000000 1.000000 63.94500 REMARK 290 SMTRY1 12 0.000000 1.000000 0.000000 77.33000 REMARK 290 SMTRY2 12 -1.000000 0.000000 0.000000 77.33000 REMARK 290 SMTRY3 12 0.000000 0.000000 1.000000 63.94500 REMARK 290 SMTRY1 13 -1.000000 0.000000 0.000000 77.33000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 77.33000 REMARK 290 SMTRY3 13 0.000000 0.000000 -1.000000 63.94500 REMARK 290 SMTRY1 14 1.000000 0.000000 0.000000 77.33000 REMARK 290 SMTRY2 14 0.000000 -1.000000 0.000000 77.33000 REMARK 290 SMTRY3 14 0.000000 0.000000 -1.000000 63.94500 REMARK 290 SMTRY1 15 0.000000 1.000000 0.000000 77.33000 REMARK 290 SMTRY2 15 1.000000 0.000000 0.000000 77.33000 REMARK 290 SMTRY3 15 0.000000 0.000000 -1.000000 63.94500 REMARK 290 SMTRY1 16 0.000000 -1.000000 0.000000 77.33000 REMARK 290 SMTRY2 16 -1.000000 0.000000 0.000000 77.33000 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 63.94500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9530 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41850 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 309.32000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 127.89000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 231.99000 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 231.99000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 63.94500 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 CL CL A 701 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 956 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1149 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 1 REMARK 465 ASP A 2 REMARK 465 ASP A 3 REMARK 465 ASP A 378 REMARK 465 ASP A 379 REMARK 465 GLN A 455 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 486 CG CD OE1 NE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ILE A 4 N CG1 CG2 CD1 REMARK 480 ILE A 5 CD1 REMARK 480 LYS A 12 CE REMARK 480 GLN A 17 NE2 REMARK 480 ARG A 40 NE REMARK 480 LYS A 44 CE REMARK 480 GLN A 47 OE1 NE2 REMARK 480 THR A 50 CB OG1 CG2 REMARK 480 LYS A 51 CB CG CD CE NZ REMARK 480 ASP A 54 CB CG OD1 OD2 REMARK 480 LYS A 60 CD NZ REMARK 480 ARG A 138 NE REMARK 480 LYS A 180 CE REMARK 480 LEU A 236 CD1 CD2 REMARK 480 TYR A 237 CD1 CD2 CE1 CE2 CZ OH REMARK 480 ARG A 240 CD NH2 REMARK 480 LYS A 248 CG CE NZ REMARK 480 GLU A 255 CB CG CD OE1 OE2 REMARK 480 GLU A 259 CG REMARK 480 LYS A 262 CD CE NZ REMARK 480 LYS A 267 CE NZ REMARK 480 ASP A 268 OD2 REMARK 480 PHE A 278 CZ REMARK 480 PRO A 281 CG CD REMARK 480 TYR A 282 CG CD1 CD2 CE1 CE2 CZ OH REMARK 480 LYS A 323 NZ REMARK 480 ASN A 342 ND2 REMARK 480 LYS A 348 CD CE NZ REMARK 480 GLU A 352 OE2 REMARK 480 ASP A 375 OD2 REMARK 480 VAL A 377 CG1 CG2 REMARK 480 LYS A 407 CD REMARK 480 GLU A 432 CD OE1 OE2 REMARK 480 ARG A 453 O CG CD NE CZ NH1 NH2 REMARK 480 GLU A 497 OE1 OE2 REMARK 480 GLN A 498 NE2 REMARK 480 GLU A 506 O OE2 REMARK 480 ARG A 509 NE REMARK 480 GLN A 517 CG CD OE1 NE2 REMARK 480 PHE A 525 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 43 -1.49 78.26 REMARK 500 ASP A 54 177.74 86.44 REMARK 500 ALA A 58 67.84 -104.12 REMARK 500 SER A 89 148.13 -173.63 REMARK 500 ASN A 106 57.79 -167.28 REMARK 500 ALA A 162 70.91 -163.48 REMARK 500 ASN A 165 19.36 55.60 REMARK 500 SER A 198 -123.76 56.01 REMARK 500 ASP A 297 -76.62 -126.05 REMARK 500 PHE A 398 -54.48 -132.11 REMARK 500 PRO A 480 47.26 -75.49 REMARK 500 ASN A 485 44.76 -105.46 REMARK 500 GLU A 506 -88.97 -60.59 REMARK 500 PHE A 525 -71.21 -70.34 REMARK 500 PHE A 526 -35.15 -39.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 HOH A 972 REMARK 615 HOH A 995 REMARK 615 NAG B 1 REMARK 615 NAG B 2 REMARK 615 FUC B 3 REMARK 615 NAG C 2 REMARK 615 FUC C 3 REMARK 615 NAG A 537 REMARK 615 NAG A 538 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1P0M RELATED DB: PDB REMARK 900 COMPLEX WITH A CHOLINE MOLECULE REMARK 900 RELATED ID: 1P0P RELATED DB: PDB REMARK 900 SOMAN-AGED BUTYRYLCHOLINESTERASE COMPLEX WITH BUTYRYLTHIOCHOLINE REMARK 900 RELATED ID: 1P0Q RELATED DB: PDB REMARK 900 SOMAN-AGED STRUCTURE OF THE HUMAN BUTYRYLCHOLINESTERASE DBREF 1P0I A 1 529 UNP P06276 CHLE_HUMAN 29 557 SEQADV 1P0I GLN A 17 UNP P06276 ASN 45 ENGINEERED MUTATION SEQADV 1P0I GLN A 455 UNP P06276 ASN 483 ENGINEERED MUTATION SEQADV 1P0I GLN A 481 UNP P06276 ASN 509 ENGINEERED MUTATION SEQADV 1P0I GLN A 486 UNP P06276 ASN 514 ENGINEERED MUTATION SEQRES 1 A 529 GLU ASP ASP ILE ILE ILE ALA THR LYS ASN GLY LYS VAL SEQRES 2 A 529 ARG GLY MET GLN LEU THR VAL PHE GLY GLY THR VAL THR SEQRES 3 A 529 ALA PHE LEU GLY ILE PRO TYR ALA GLN PRO PRO LEU GLY SEQRES 4 A 529 ARG LEU ARG PHE LYS LYS PRO GLN SER LEU THR LYS TRP SEQRES 5 A 529 SER ASP ILE TRP ASN ALA THR LYS TYR ALA ASN SER CYS SEQRES 6 A 529 CYS GLN ASN ILE ASP GLN SER PHE PRO GLY PHE HIS GLY SEQRES 7 A 529 SER GLU MET TRP ASN PRO ASN THR ASP LEU SER GLU ASP SEQRES 8 A 529 CYS LEU TYR LEU ASN VAL TRP ILE PRO ALA PRO LYS PRO SEQRES 9 A 529 LYS ASN ALA THR VAL LEU ILE TRP ILE TYR GLY GLY GLY SEQRES 10 A 529 PHE GLN THR GLY THR SER SER LEU HIS VAL TYR ASP GLY SEQRES 11 A 529 LYS PHE LEU ALA ARG VAL GLU ARG VAL ILE VAL VAL SER SEQRES 12 A 529 MET ASN TYR ARG VAL GLY ALA LEU GLY PHE LEU ALA LEU SEQRES 13 A 529 PRO GLY ASN PRO GLU ALA PRO GLY ASN MET GLY LEU PHE SEQRES 14 A 529 ASP GLN GLN LEU ALA LEU GLN TRP VAL GLN LYS ASN ILE SEQRES 15 A 529 ALA ALA PHE GLY GLY ASN PRO LYS SER VAL THR LEU PHE SEQRES 16 A 529 GLY GLU SER ALA GLY ALA ALA SER VAL SER LEU HIS LEU SEQRES 17 A 529 LEU SER PRO GLY SER HIS SER LEU PHE THR ARG ALA ILE SEQRES 18 A 529 LEU GLN SER GLY SER PHE ASN ALA PRO TRP ALA VAL THR SEQRES 19 A 529 SER LEU TYR GLU ALA ARG ASN ARG THR LEU ASN LEU ALA SEQRES 20 A 529 LYS LEU THR GLY CYS SER ARG GLU ASN GLU THR GLU ILE SEQRES 21 A 529 ILE LYS CYS LEU ARG ASN LYS ASP PRO GLN GLU ILE LEU SEQRES 22 A 529 LEU ASN GLU ALA PHE VAL VAL PRO TYR GLY THR PRO LEU SEQRES 23 A 529 SER VAL ASN PHE GLY PRO THR VAL ASP GLY ASP PHE LEU SEQRES 24 A 529 THR ASP MET PRO ASP ILE LEU LEU GLU LEU GLY GLN PHE SEQRES 25 A 529 LYS LYS THR GLN ILE LEU VAL GLY VAL ASN LYS ASP GLU SEQRES 26 A 529 GLY THR ALA PHE LEU VAL TYR GLY ALA PRO GLY PHE SER SEQRES 27 A 529 LYS ASP ASN ASN SER ILE ILE THR ARG LYS GLU PHE GLN SEQRES 28 A 529 GLU GLY LEU LYS ILE PHE PHE PRO GLY VAL SER GLU PHE SEQRES 29 A 529 GLY LYS GLU SER ILE LEU PHE HIS TYR THR ASP TRP VAL SEQRES 30 A 529 ASP ASP GLN ARG PRO GLU ASN TYR ARG GLU ALA LEU GLY SEQRES 31 A 529 ASP VAL VAL GLY ASP TYR ASN PHE ILE CYS PRO ALA LEU SEQRES 32 A 529 GLU PHE THR LYS LYS PHE SER GLU TRP GLY ASN ASN ALA SEQRES 33 A 529 PHE PHE TYR TYR PHE GLU HIS ARG SER SER LYS LEU PRO SEQRES 34 A 529 TRP PRO GLU TRP MET GLY VAL MET HIS GLY TYR GLU ILE SEQRES 35 A 529 GLU PHE VAL PHE GLY LEU PRO LEU GLU ARG ARG ASP GLN SEQRES 36 A 529 TYR THR LYS ALA GLU GLU ILE LEU SER ARG SER ILE VAL SEQRES 37 A 529 LYS ARG TRP ALA ASN PHE ALA LYS TYR GLY ASN PRO GLN SEQRES 38 A 529 GLU THR GLN ASN GLN SER THR SER TRP PRO VAL PHE LYS SEQRES 39 A 529 SER THR GLU GLN LYS TYR LEU THR LEU ASN THR GLU SER SEQRES 40 A 529 THR ARG ILE MET THR LYS LEU ARG ALA GLN GLN CYS ARG SEQRES 41 A 529 PHE TRP THR SER PHE PHE PRO LYS VAL MODRES 1P0I ASN A 57 ASN GLYCOSYLATION SITE MODRES 1P0I ASN A 106 ASN GLYCOSYLATION SITE MODRES 1P0I ASN A 241 ASN GLYCOSYLATION SITE MODRES 1P0I ASN A 341 ASN GLYCOSYLATION SITE MODRES 1P0I ASN A 485 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET FUC B 3 10 HET NAG C 1 14 HET NAG C 2 14 HET FUC C 3 10 HET NAG A 536 14 HET NAG A 537 14 HET NAG A 538 14 HET SO4 A 601 5 HET SO4 A 602 5 HET CL A 701 1 HET CL A 702 1 HET BUA A 606 6 HET MES A 607 12 HET GOL A 603 6 HET GOL A 604 6 HET GOL A 605 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM SO4 SULFATE ION HETNAM CL CHLORIDE ION HETNAM BUA BUTANOIC ACID HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETNAM GOL GLYCEROL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 NAG 7(C8 H15 N O6) FORMUL 2 FUC 2(C6 H12 O5) FORMUL 7 SO4 2(O4 S 2-) FORMUL 9 CL 2(CL 1-) FORMUL 11 BUA C4 H8 O2 FORMUL 12 MES C6 H13 N O4 S FORMUL 13 GOL 3(C3 H8 O3) FORMUL 16 HOH *483(H2 O) HELIX 1 1 LEU A 38 ARG A 42 5 5 HELIX 2 2 PHE A 76 MET A 81 1 6 HELIX 3 3 LEU A 125 ASP A 129 5 5 HELIX 4 4 GLY A 130 ARG A 138 1 9 HELIX 5 5 VAL A 148 LEU A 154 1 7 HELIX 6 6 ASN A 165 ILE A 182 1 18 HELIX 7 7 ALA A 183 PHE A 185 5 3 HELIX 8 8 SER A 198 SER A 210 1 13 HELIX 9 9 PRO A 211 PHE A 217 5 7 HELIX 10 10 SER A 235 THR A 250 1 16 HELIX 11 11 ASN A 256 ARG A 265 1 10 HELIX 12 12 ASP A 268 ALA A 277 1 10 HELIX 13 13 PHE A 278 VAL A 280 5 3 HELIX 14 14 MET A 302 LEU A 309 1 8 HELIX 15 15 GLY A 326 VAL A 331 1 6 HELIX 16 16 THR A 346 PHE A 358 1 13 HELIX 17 17 SER A 362 THR A 374 1 13 HELIX 18 18 GLU A 383 PHE A 398 1 16 HELIX 19 19 PHE A 398 GLU A 411 1 14 HELIX 20 20 PRO A 431 GLY A 435 5 5 HELIX 21 21 GLU A 441 PHE A 446 1 6 HELIX 22 22 GLY A 447 GLU A 451 5 5 HELIX 23 23 THR A 457 GLY A 478 1 22 HELIX 24 24 ARG A 515 SER A 524 1 10 SHEET 1 A 3 ILE A 5 THR A 8 0 SHEET 2 A 3 GLY A 11 ARG A 14 -1 O VAL A 13 N ILE A 6 SHEET 3 A 3 ILE A 55 ASN A 57 1 O TRP A 56 N LYS A 12 SHEET 1 B11 MET A 16 VAL A 20 0 SHEET 2 B11 GLY A 23 PRO A 32 -1 O VAL A 25 N LEU A 18 SHEET 3 B11 TYR A 94 PRO A 100 -1 O LEU A 95 N ILE A 31 SHEET 4 B11 ILE A 140 MET A 144 -1 O SER A 143 N ASN A 96 SHEET 5 B11 ALA A 107 ILE A 113 1 N TRP A 112 O VAL A 142 SHEET 6 B11 GLY A 187 GLU A 197 1 O ASN A 188 N ALA A 107 SHEET 7 B11 ARG A 219 GLN A 223 1 O GLN A 223 N GLY A 196 SHEET 8 B11 ILE A 317 ASN A 322 1 O LEU A 318 N LEU A 222 SHEET 9 B11 ALA A 416 PHE A 421 1 O PHE A 421 N VAL A 321 SHEET 10 B11 LYS A 499 LEU A 503 1 O LEU A 501 N TYR A 420 SHEET 11 B11 ILE A 510 THR A 512 -1 O MET A 511 N TYR A 500 SSBOND 1 CYS A 65 CYS A 92 1555 1555 2.07 SSBOND 2 CYS A 252 CYS A 263 1555 1555 2.04 SSBOND 3 CYS A 400 CYS A 519 1555 1555 2.06 LINK ND2 ASN A 57 C1 NAG A 537 1555 1555 1.45 LINK ND2 ASN A 106 C1 NAG A 536 1555 1555 1.45 LINK OG SER A 198 C4 BUA A 606 1555 1555 2.16 LINK ND2 ASN A 241 C1 NAG B 1 1555 1555 1.45 LINK ND2 ASN A 341 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN A 485 C1 NAG A 538 1555 1555 1.45 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.39 LINK O6 NAG B 1 C1 FUC B 3 1555 1555 1.40 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.38 LINK O6 NAG C 1 C1 FUC C 3 1555 1555 1.41 CISPEP 1 ALA A 101 PRO A 102 0 -0.22 CRYST1 154.660 154.660 127.890 90.00 90.00 90.00 I 4 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006466 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006466 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007819 0.00000